Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04094701 · ClinicalTrials.gov registry record · NA

Hip Arthroscopy Postoperative Opioid Demands

A NA study of Pain and Opioid Use, sponsored by Rush University Medical Center.

Recruiting
Registry status
NA
Development phase
170
Enrollment target
1
Study location

NCT04094701 is a NA study of Pain and Opioid Use that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 170 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04094701, a NA study of Pain and Opioid Use, is actively recruiting participants, sponsored by Rush University Medical Center.

RECRUITING
Registry status
NA
Development phase
170 participants
Enrollment target
1
Study location

Study Summary

This study will be a prospective, single-blinded, randomized controlled trial (RCT), investigating the influence of the number of opioid pills prescribed following primary hip arthroscopy. All patients who sign the consent form will be enrolled in the suited and randomized to one of the two treatment arms. The intervention group will receive 5 Norco pills, gabapentin (30 mg, once daily for 10 days following surgery), and Tylenol (1000 mg, three times daily for 10 days following surgery) while the control will receive the standard at our practice of 30 Norco pills.

Interventions

  • OTHER Control Group Regimen
  • OTHER Opioid reduced regimen

Study Locations (1)

Illinois

  • Rush University Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 170 participants
Start Date 2020-10-21
Est. Completion 2027-03
Phase NA

Sponsor

Rush University Medical Center

320 total trials

What the Registry Record Tells You About NCT04094701

The ClinicalTrials.gov registry entry for NCT04094701 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (44% lower). The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Control Group Regimen is the first listed.

NCT04094701 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04094701 about?

NCT04094701 is a clinical study titled "Hip Arthroscopy Postoperative Opioid Demands". This study will be a prospective, single-blinded, randomized controlled trial (RCT), investigating the influence of the number of opioid pills prescribed following primary hip arthroscopy. All patients who sign the consent form will be enrolled in the suited and randomized to one of the two treatmen...

What is the current status of trial NCT04094701?

This trial is currently recruiting. It is a NA study. The enrollment target is 170 participants. The study started on 2020-10-21. Estimated completion is 2027-03.

What conditions does trial NCT04094701 study?

This clinical trial studies the following conditions: Pain, Opioid Use, Femoral Acetabular Impingement, Labral Tear, Glenoid.

What interventions are being tested in trial NCT04094701?

The interventions under investigation include: Control Group Regimen (OTHER), Opioid reduced regimen (OTHER).

Who is sponsoring clinical trial NCT04094701?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04094701 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.